• Medicine
• Published in
  Canadian journal of…
  2009
• DOI:10.3129/i09-126

Varicella zoster virus vaccines: effective, but concerns linger.

@article{Liesegang2009VaricellaZV,
  title={Varicella zoster virus vaccines: effective, but concerns linger.},
  author={Thomas J. Liesegang},
  journal={Canadian journal of ophthalmology. Journal canadien d'ophtalmologie},
  year={2009},
  volume={44 4},
  pages={
          379-84
        }
}

• Thomas J. Liesegang

Both varicella and herpes zoster (HZ) can cause severe disease in certain age groups. The cell-mediated immune (CMI) response to the varicella zoster virus (VZV) is critical in preventing a recurrence of VZV. The varicella vaccine has markedly decreased the morbidity and mortality associated with varicella, but concerns linger about the cost and frequency of vaccine administration and the long-term effects on both adult varicella and HZ epidemiology in the individual and in the population… CONTINUE READING

View PDF

Save to Library

Create Alert

Cite